Mingowood Pharmacal

Mingowood PharmacalMingowood PharmacalMingowood Pharmacal
  • Home
  • Mission
  • Benefits
  • Better Medicine
  • Technology
    • Our Science
    • Demonstration
    • Stability Studies
    • ATR-FTIR
    • FAQ
    • Patents
  • About
    • Monetization Model
    • Announcements
    • Leadership
  • Contact
  • More
    • Home
    • Mission
    • Benefits
    • Better Medicine
    • Technology
      • Our Science
      • Demonstration
      • Stability Studies
      • ATR-FTIR
      • FAQ
      • Patents
    • About
      • Monetization Model
      • Announcements
      • Leadership
    • Contact

Mingowood Pharmacal

Mingowood PharmacalMingowood PharmacalMingowood Pharmacal
  • Home
  • Mission
  • Benefits
  • Better Medicine
  • Technology
    • Our Science
    • Demonstration
    • Stability Studies
    • ATR-FTIR
    • FAQ
    • Patents
  • About
    • Monetization Model
    • Announcements
    • Leadership
  • Contact

Benefits of Acidic Cannabinoids

Stabilizing Acidic Cannabinoids & Beyond

Our @LDH™ formulation technology’s ability to intercalate acidic cannabinoids is a game-changer. This ensures consistent and stable formulations and enhances the shelf life, potency, and bioavailability of acidic cannabinoids.

Unlocking Stability: Mingowood's @LDH™ Formulation Technology

Stability is paramount in the world of acidic cannabinoids. Mingowood Pharmacal spearheads innovation with its revolutionary @LDH™ formulation technology, providing a transformative solution for stabilizing these vital compounds.

The Stability Challenge

 Acidic cannabinoids, particularly CBDA, THCA, CBGA, and CBCA, are subject to rapid degradation from the time of purification. Environmental factors like light, heat, and oxygen degrade acidic cannabinoids, decreasing their potency, efficacy, and shelf life, thereby diminishing their therapeutic benefits.

@LDH™: A Shield of Stability

Mingowood Pharmacal's @LDH™ formulation technology acts as a shield, intercalating acidic cannabinoids in layered hydroxides to safeguard their active compounds. This innovative approach creates a stable matrix, shielding against external elements and ensuring extract integrity from production to consumption.

Key Benefits of @LDH™ Formulation Technology

  • Preservation of Potency: @LDH™ safeguards the molecular structure of acidic      cannabinoids, preserving their therapeutic potency.
  • Enhanced Bioavailability: By preventing degradation, @LDH™ maximizes the      bioavailability of active compounds, ensuring the body readily absorbs them.
  • Enhanced and predictable dosing accuracy: @LDH™ delivers consistent CBDA, CBGA, and THCA concentrations, batch by batch, resulting in precise dosing and reliability in the finished product.
  • Extended Shelf Life: @LDH™ protects acidic cannabinoid extracts from environmental      factors, significantly extending product shelf life beyond two years.
  • Versatile Application: Mingowood's @LDH™ formulation technology is adaptable to CBDA, THCA, GBGA, and GBCA, stabilizing these key cannabinoid extracts.

Empowering Your Formulations

Mingowood Pharmacal's @LDH™ formulation technology empowers products with unmatched stability. Whether you are developing wellness products, pain relief formulations, or ethical pharmaceuticals, partner with Mingowood to unlock the full potential of stability with @LDH™.

Mingowood Pharmacal

Copyright © 2024 Mingowood Pharmacal - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept